ClinicalTrials.gg
CompletedNCT05936983Updated Jul 10, 2023

Comparison of Physical Fitness, Physical Activity Level in Patients With Bipolar Disorder and Schizophrenia

An observational study in Bipolar Disorder and Schizophrenia, sponsored by Yeditepe University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 30 Years to 55 Years. Per ClinicalTrials.gov, last updated 2023-07-10.

Sponsored by Yeditepe University · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
90
Ages
30 Years to 55 Years
Sex
All
01

Study summary

According to the World Health Organization; Bipolar disorder ranks in the top 20 causes of disability among all medical conditions and 6th among mental disorders worldwide. Bipolar disorder is noted as a serious mental illness involving emotional ups and downs.

Read the detailed description

Schizophrenia is a chronic mental disorder characterized by the appearance of both positive symptoms such as hallucinations and delusions and negative symptoms such as apathy and withdrawal, repetition of cognitive skills, and disorganization. In this study, it was aimed to compare physical fitness, physical activity level, depression and quality of life in bipolar disoder and schizophrenic patients with healthy individuals.

02

Conditions studied

  • Bipolar Disorder
  • Schizophrenia
03

In context

Bipolar Disorder

1,637 studies on the registry are indexed under Bipolar Disorder; 258 are open to participants now.

This study's enrollment of 90 is below the median of 158 across 339 observational studies indexed under Bipolar Disorder.

Browse Bipolar Disorder studies →

Lead sponsor

Yeditepe University is the lead sponsor of 131 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 55 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

patients with Bipolar disorder and schizophrenia come to the community mental health center regularly

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals diagnosed with bipolar disorder and schizophrenia by a physician according to DSM-5 criteria

    • Individuals with bipolar and schizophrenia between the ages of 30-55
    • Patients without any other accompanying psychiatric disorder
    • Patients who can communicate
    • Patients who agreed to participate in this study and gave informed consent

Exclusion criteria

Exclusion Criteria:

  • Patients with a psychiatric diagnosis other than bipolar and schizophrenia.
  • Pregnancy condition
  • Those who did not consent to participate in the study
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
90 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients with Bipolar disorder

    Participants will be asked to fill out a structured questionnaire containing their sociodemographic characteristics. Then, Anthropometric Measurements, Eurofit test battery, Rapid Depressive Symptom Inventory-Self-Report Form and International physical activity questionnaire will be applied respectively.

  • Patients with Schizophrenia group

    Participants will be asked to fill out a structured questionnaire containing their sociodemographic characteristics. Then, Anthropometric Measurements, Eurofit test battery, Rapid Depressive Symptom Inventory-Self-Report Form and International physical activity questionnaire will be applied respectively.

  • Healthy group

    Participants will be asked to fill out a structured questionnaire containing their sociodemographic characteristics. Then, Anthropometric Measurements, Eurofit test battery, Rapid Depressive Symptom Inventory-Self-Report Form and International physical activity questionnaire will be applied respectively.

06

What researchers measure

Primary outcomes

  1. Waist measurement - Antropometric Measurements

    Waist measurement is measured from the narrowest area between the subcostal region and the iliac crest.

    Time frame: 4 weeks

  2. Abdomen measurement - Antropometric Measurements

    Abdomen measurement is measured at the level of the umbilicus without compression of the tissues.

    Time frame: 4 weeks

  3. The hip measurement - Antropometric Measurements

    The hip measurement is measured from the thickest part of the hip area.

    Time frame: 4 weeks

  4. Eurofit Test Battery

    A test-retest design was applied to test the reproducibility of several Eurofit test battery items. Supervision and measurement of the Eurofit test battery was performed by one trained mental health physical therapist following a standardized procedure. The Eurofit test battery included seven items and involved the assessment of the following measures: whole body balance, speed of limb movement, flexibility, explosive strength, static strength, abdominal muscular endurance and running speed.

    Time frame: 4 weeks

  5. Quick Inventory of Depressive Symptomatology (QIDS-SR16) scale

    QIDS-SR consists of 16 items each ranging from 0 to 3. It is scored by summing the highest response in each of a set of questions relating to sleep, weight and psychomotor symptoms and then adding the remaining items

    Time frame: 4 weeks

  6. International Physical Activity Questionnaire

    The IPAQ questionnaires list activities and request estimates of durations and frequencies for each activity engaged in over the past week. Durations are multiplied by known METs per activity and the results for all items are summed for the overall physical activity score. Scores for walking and for moderate and vigorous activities are sums of corresponding item scores. A sitting question is not included in physical activity score.

    Time frame: 4 weeks

07

Study locations

1 site
  • Yeditepe University
    Istanbul, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 10, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05936983
Responsible party
Sponsor
First posted
Jul 10, 2023
Start date
Jun 2, 2023
Primary completion
Jun 15, 2023
Completion
Jun 20, 2023
Last update
Jul 10, 2023

Study contacts

Ebru Akbuğa Koç
principal investigator · Yeditepe University
İsmail Koç
principal investigator · Dr. Lutfi Kirdar Kartal Training and Research Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion